<i>MYCN</i> drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity
Eli Grunblatt(Fred Hutch Cancer Center), David MacPherson(University of Washington)
Cited by 89
Related Papers
Inhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing
|Clinical Cancer Research|2022|115
A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence
|Journal of Clinical Investigation|2017|48
Cooperation between Rb and Arf in suppressing mouse retinoblastoma
|Journal of Clinical Investigation|2012|24